{
    "medicine_id": "c888b87cc7120e996847087c7d28560d9a26a99b",
    "platform_id": "DB05230",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g AC3056",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of atherosclerosis and other conditions related to the obstruction of blood vessels",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Oral administration of AC3056 results in dose dependent antioxidant activity and was well tolerated In 2002 positive results were reported from a phase I trial In the double blind placebo controlled crossover trial 14 healthy subjects received an oral formulation of AC3056 in a dose escalating manner Results demonstrated dose dependent increases in blood levels of AC3056 as well as dose dependent increases in serum antioxidant activity The drug was well tolerated with no safety concerns",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}